Relating to right to try individualized treatments

SB 594 allows West Virginia patients with life-threatening or severely debilitating illnesses to access personalized investigational treatments (like gene therapies or vaccines tailored to their genetics) when all FDA-approved options have been exhausted. It requires written consent from the patient (or guardian) and a treating physician's attestation confirming other treatments are unlikely to prolong life, along with detailed risk disclosures. The bill prohibits health care providers from facing sanctions for offering such treatments, prevents debt collection from estates after a patient's death related to these treatments, and clarifies that health insurance plans aren't obligated to cover costs. It directly affects terminally ill patients, their physicians, and manufacturers of individualized treatments, while ensuring no changes to existing clinical trial coverage obligations.